(1.37%) 5 133.67 points
(1.29%) 38 718 points
(2.13%) 16 178 points
(-0.77%) $78.34
(4.96%) $2.14
(0.07%) $2 311.30
(-0.47%) $26.70
(0.33%) $965.75
(-0.36%) $0.929
(-1.19%) $10.86
(-0.12%) $0.797
(0.37%) $91.47
2.31% $ 77.51
@ $76.59
Wydano: 3 geg. 2024 @ 18:33
Zwrot: 1.21%
Poprzedni sygnał: geg. 2 - 20:44
Poprzedni sygnał:
Zwrot: 1.55 %
Live Chart Being Loaded With Signals
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders...
Stats | |
---|---|
Dzisiejszy wolumen | 2.65M |
Średni wolumen | 6.51M |
Kapitalizacja rynkowa | 8.55B |
EPS | $-0.250 ( 2024-04-24 ) |
Następna data zysków | ( $-0.250 ) 2024-07-24 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -84.25 |
ATR14 | $4.80 (6.20%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-05-01 | Mancini Marianna | Buy | 51 000 | Common Stock, par value $0.00001 per share |
2024-05-01 | Mancini Marianna | Sell | 23 746 | Common Stock, par value $0.00001 per share |
2024-05-01 | Mancini Marianna | Sell | 26 142 | Common Stock, par value $0.00001 per share |
2024-05-01 | Mancini Marianna | Buy | 35 426 | Common Stock, par value $0.00001 per share |
2024-05-01 | Mancini Marianna | Buy | 90 000 | Common Stock, par value $0.00001 per share |
INSIDER POWER |
---|
1.01 |
Last 100 transactions |
Buy: 2 844 296 | Sell: 2 903 733 |
Wolumen Korelacja
Viking Therapeutics Inc Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
CFFE | 0.97 |
ARIZ | 0.966 |
EMLD | 0.96 |
ARTEU | 0.96 |
AIB | 0.958 |
GENQ | 0.956 |
FTII | 0.956 |
ABST | 0.955 |
GDST | 0.955 |
KIN | 0.954 |
10 Najbardziej negatywne korelacje | |
---|---|
SMFL | -0.968 |
CYAN | -0.963 |
MYSZ | -0.96 |
PIII | -0.958 |
CREG | -0.955 |
BCAB | -0.95 |
PYR | -0.95 |
SPCX | -0.949 |
KTTA | -0.948 |
VFF | -0.947 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Viking Therapeutics Inc Korelacja - Waluta/Towar
Viking Therapeutics Inc Finanse
Annual | 2023 |
Przychody: | $0 |
Zysk brutto: | $-292 000 (0.00 %) |
EPS: | $-0.910 |
FY | 2023 |
Przychody: | $0 |
Zysk brutto: | $-292 000 (0.00 %) |
EPS: | $-0.910 |
FY | 2022 |
Przychody: | $0 |
Zysk brutto: | $-291 000 (0.00 %) |
EPS: | $-0.880 |
FY | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-0.757 |
Financial Reports:
No articles found.
Viking Therapeutics Inc
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. It also develops VK5211, an orally available non-steroidal selective androgen receptor modulator that is in Phase II clinical trials for the treatment of patients recovering from non-elective hip fracture surgery; VK0612, an orally available Phase IIb-ready drug candidate for type 2 diabetes; and VK0214, an orally available tissue and receptor-subtype selective agonist of the TRß for X-linked adrenoleukodystrophy. The company was incorporated in 2012 and is headquartered in San Diego, California.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej